Ján Koreň

Dr. Ján Koreň

Faculty of Medicine, Comenius University Bratislava, Bratislava, Bratislavský, Slovakia
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
JKJán Koreň
Ján Koreň
MAMichal Andrezál
Michal Andrezál
HDHana Drahovská
Hana Drahovská
ZHZuzana Hubenáková
Zuzana Hubenáková
Adriána LiptákováAdriána Liptáková
Adriána Liptáková
TMTibor Maliar
Tibor Maliar
Carbapenem-resistant (CR) Klebsiella pneumoniae represents an urgent worldwide threat. We focused on CR K. pneumoniae in selected facilities of the University Hospital Bratislava (UHB) to investigate sequence types (STs), clonal relatedness, and antimicrobial resistance. Suspected carbapenem-nonsusceptible K. pneumoniae strains were obtained from hospitalized patients. Further examination included carbapenemase confirmation, cgMLST, and quantitative susceptibility testing. Of the total 41 CR K. pneumoniae strains, 26 (63.4%) were determined as ST11 in hospital No. 1; of these ST11, 22 (84.6%) were found in the first internal clinic. Six (14.6%) ST258 and three (7.3%) ST584 occurred in hospital No. 2; the most, i.e., four (66.7%), ST258 were detected in the geriatric clinic. In hospital No. 3, we found two (4.8%) ST584 and one (2.4%) ST258. Of the ST11 set, 24 (92.3%) produced NDM-1. Furthermore, seven (87.5) ST258 and five (100%) ST584 strains generated KPC-2. Antimicrobial resistance was as follows: ertapenem 97.6%, meropenem 63.4%, tigecycline 7.3%, eravacycline 7.3%, and colistin 2.5%. We revealed a presumably epidemiological association of ST11 with transmission, particularly in the first internal clinic of hospital No. 1, while ST258 and ST584 were related to interhospital dissemination between medical facilities No. 2 and No. 3. It is essential to prevent the circulation of these pathogens within and between healthcare facilities.

1 January 2019 in Bratislava Medical Journal
Verified
Journal Article
Closed access
JKJán Koreň
Ján Koreň
ZHZ. Hubenakova
Z. Hubenakova
HDH. Drahovska
H. Drahovska
EOE. Ozaee
E. Ozaee
BMB. Markuskova
B. Markuskova
ALA. Lichvarikova
A. Lichvarikova
Emergence of extended-spectrum β-lactamase (ESBL) and/or carbapenemase producing Enterobacteriaceae (CPE) and their antimicrobial resistance

21 June 2012 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
JKJán Koreň
Ján Koreň
KČKatarína Čurová
Katarína Čurová
MKMarta Kmeťová
Marta Kmeťová
LSLeonard Siegfried
Leonard Siegfried
VJViktor Jankó
Viktor Jankó
JLJán Luha
Ján Luha

20 July 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
JKJán Koreň
Ján Koreň
MAMichal Andrezál
Michal Andrezál
EOElham Ozaee
Elham Ozaee
HDHana Drahovská
Hana Drahovská
MWMartin Wawruch
Martin Wawruch
TMTibor Maliar
Tibor Maliar
The expansion of sequence type 131 (ST131) extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) represents major worldwide challenges. E. coli strains originating from healthcare facilities (labeled No. 1 and No. 2) of the University Hospital Bratislava (UHB) were analyzed for ST131 emergence, including its (sub)lineages and clonal relatedness. Antimicrobial resistance was determined in most strains. Of a total of 354 E. coli strains, 263 (74.3%) belonged to ST131; of these, 177 (67.3%) were from No. 1. Generally, among 260 ST131 E. coli, clades A/B were confirmed in 20 (7.7%), while clade C was noted in 240 (92.3%) strains; within them, subclades were detected as follows: C0 (17; 7.1%), C1 (3; 1.2%), and C2 (220; 91.7%). Among fifteen randomly selected E. coli strains that were investigated for ST and clonal relatedness, seven STs were identified: eight (53.3%) ST131, two (13.3%) ST73, and one each (6.7%) of ST10, ST12, ST14, ST1193, and ST1196. From No. 1, two ST131 in the first internal clinic and one ST131 from No. 2 in the aftercare department were highly clonally related, suggesting possible epidemiological association. Antimicrobial resistance was as follows: ciprofloxacin 93.8%, ceftazidime 78.4%, meropenem 0%, fosfomycin 2.9% and nitrofurantoin 1.4%. Prevention of ESBL-producing E. coli dissemination, especially for ST131 clade C2, is inevitably necessary for reducing drug resistance and decreasing healthcare-associated infections.

27 February 2025 in Journal of microbiology, biotechnology and food sciences
Verified
Journal Article
Open access
PDF file
TMTibor Maliar
Tibor Maliar
MBMarcela Blažková
Marcela Blažková
MKMarek Kunštek
Marek Kunštek
MMMária Maliarová
Mária Maliarová
JSJozef Sokol
Jozef Sokol
JKJán Koreň
Ján Koreň
An original engine has been developed for the frugal extraction of plant extractive compounds with an accelerating effect. It operates on the principle of simultaneously combining several physical factors (sonication, temperature, and electrical field) to promote extraction. By applying this engine, plant extract samples were obtained with significantly enhanced dry matter content as well as bioactivity, particularly in antioxidant, antibacterial, enzyme inhibition, and anti-inflammatory activities. This device was utilized in the process of preparing four selected extract samples, which exhibited significant simultaneous antibacterial activity, inhibition activity on the main protease of SARS-CoV-2, antioxidant activity, as well as anti-inflammatory activity. Particularly, these activities were expressed mainly in the following extract samples: from the bark of oak (Quercus robur, L.), the flower of oregano (Origanum vulgare L.), grains of rapeseed (Brassica napus subsp. oleifera,) and grains of oat (Avena sativa L.). The activity enhancement factor (coefficient) varied in the interval of (2.8 - 6.2). The extraction products were prepared for the development of new food supplements for pandemic situations, aimed at enhancing the body's defenses. The analytical aspects as well as elicitation perspectives for the continuing research are discussed.

26 November 2018 in Biologia
Verified
Journal Article
Closed access
PDF file
JKJán Koreň
Ján Koreň
VHVladimír Hrabovský
Vladimír Hrabovský
MKMarta Kmeťová
Marta Kmeťová
LSLeonard Siegfried
Leonard Siegfried
MRMagdaléna Röderová
Magdaléna Röderová
Adriána LiptákováAdriána Liptáková
Adriána Liptáková